Belinda Graham, MD
Allergy & Immunology · Smyrna, GANPI 1770786915
Payments from drug & device makers
Across 688 payments — averaging $137.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$58K
- GSK$14K
- AstraZeneca$7K
- Genentech, Inc.$4K
- Sanofi$3K
- Novartis$3K
- plus $6K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 122 | $58,255 |
| GSK | 98 | $13,866 |
| AstraZeneca | 87 | $6,935 |
| Genentech, Inc. | 6 | $4,220 |
| Sanofi | 97 | $2,768 |
| Novartis | 24 | $2,741 |
| Optinose US, Inc. | 67 | $932 |
| Amgen(2 entities) | 46 | $926 |
| Takeda Pharmaceuticals U.S.A., Inc. | 30 | $718 |
| Blueprint Medicines Corporation | 6 | $393 |
| Covis Pharma GmbH | 15 | $344 |
| Biocryst US Sales Co., LLC | 10 | $344 |
| Pfizer | 12 | $260 |
| Pharming Healthcare, Inc. | 10 | $254 |
| Genentech USA, Inc. | 7 | $233 |
| Grifols USA, LLC | 9 | $181 |
| Sanofi-aventis U.S. LLC | 2 | $154 |
| Kaleo, Inc. | 9 | $147 |
| CSL Behring | 6 | $143 |
| Teva Pharmaceuticals USA, Inc. | 6 | $105 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $86 |
| Alk-abello, Inc | 3 | $51 |
| Phadia US Inc. | 3 | $44 |
| Boehringer Ingelheim | 2 | $37 |
| Abbott | 1 | $30 |
| Galderma Laboratories, L.p. | 1 | $25 |
| Azurity Pharmaceuticals, Inc. | 1 | $23 |
| Arcutis Biotherapeutics, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $20 |
| Shire North American Group Inc | 1 | $20 |
| Incyte Corporation | 1 | $19 |
| Greer Laboratories, Inc. | 1 | $19 |
| Merck | 1 | $15 |
| Regeneron | 1 | $13 |
How this compares
$94,343 in reported general payments places this provider in the 85th percentile of 107 allergy & immunology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Smyrna
- Nathan SegallStockbridge$4.5M
- Tracy BridgesAlbany$1.5M
- Brad GoodmanSavannah$1.3M
- Michael BlaissRoswell$1.1M
- Robert ChrzanowskiColumbus$941K
- Stanley FinemanMarietta$855K
- Robert CartwrightColumbus$678K
- Deborah BirxAtlanta$470K
- Jack EadesMacon$282K
- Bruce FinkelSavannah$277K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.